TROV - .79 Pre-market now at .88/.92 Trovagene's PLK1 Inhibitor (PCM-075) Demonstrates Synergy with Zytiga® (abiraterone acetate) in Castration Resistant Prostate Cancer Tumor Cells http://stockcharts.com/c-sc/sc?s=TROV&p=D&b=5&g=0&i=t48918090728&r=1508328704226 http://stockcharts.com/c-sc/sc?s=TROV&p=W&b=5&g=0&i=t57973269690&r=1508328725063